Trials / Completed
CompletedNCT05664555
Dose Optimization for Safe and Efficient Fluorescein Angiography (DOSE Study)
Low Dose Fluorescein Angiography Comparing 1mL and 3mL of 10% Fluorescein: A Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 144 (actual)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to compare the efficacy and safety of fluorescein angiography using 1mL versus 3mL of 10% fluorescein dye.
Detailed description
The investigators will recruit patients who need fluorescein angiography for their retinal diseases. The investigators will collect data on image quality and complications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluorescein Sodium | Patients will receive Fluorescein Sodium 3mL (300mg) or 1mL (100mg) intravenously prior to fluorescein angiography. |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2024-03-31
- Completion
- 2024-03-31
- First posted
- 2022-12-23
- Last updated
- 2024-04-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05664555. Inclusion in this directory is not an endorsement.